74 related articles for article (PubMed ID: 12756846)
1. [Dipeptidyl peptidase IV (DPP IV, CD 26): a tumor marker in cytologic and histopathologic diagnosis of lesions of the thyroid gland].
Kholová I; Ryska A; Ludvíková M; Pecen L; Cáp J
Cas Lek Cesk; 2003 Mar; 142(3):167-71. PubMed ID: 12756846
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification.
Kholová I; Ludvíková M; Ryska A; Hanzelková Z; Cap J; Pecen L; Topolcan O
Neoplasma; 2003; 50(3):159-64. PubMed ID: 12937847
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
Kholová I; Ludvíkova M; Ryska A; Topolcan O; Pikner R; Pecen L; Cáp J; Holubec L
Anticancer Res; 2003; 23(2A):871-5. PubMed ID: 12820316
[TBL] [Abstract][Full Text] [Related]
4. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
[TBL] [Abstract][Full Text] [Related]
6. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.
Kotani T; Asada Y; Aratake Y; Umeki K; Yamamoto I; Tokudome R; Hirai K; Kuma K; Konoe K; Araki Y
J Pathol; 1992 Sep; 168(1):41-5. PubMed ID: 1360496
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity].
Zoro P; Vassko V; Garcia S; Pazart L; Aho S; De Micco C
Ann Pathol; 1996 Sep; 16(4):261-5. PubMed ID: 9172614
[TBL] [Abstract][Full Text] [Related]
9. Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours: a possible marker of thyroid malignancy.
Tang AC; Raphael SJ; Lampe HB; Matthews TW; Becks GP
J Otolaryngol; 1996 Feb; 25(1):14-9. PubMed ID: 8816103
[TBL] [Abstract][Full Text] [Related]
10. [Dipeptidyl(amino)peptidase IV in the differential diagnosis of thyroid gland tumors: methods and results of a pilot study of 200 cases].
Kholová I; Ludvíková M; Ryska A; Cáp J
Cesk Patol; 2002 Jan; 38(1):11-7. PubMed ID: 11933456
[TBL] [Abstract][Full Text] [Related]
11. The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma.
Chandan VS; Faquin WC; Wilbur DC; Khurana KK
Cancer; 2006 Oct; 108(5):331-6. PubMed ID: 16944537
[TBL] [Abstract][Full Text] [Related]
12. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
Wang SL; Li SH; Chen WT; Chai CY
APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase IV expression in thyroid cytology: retrospective histologically confirmed study.
Kholová I; Ryska A; Ludvíková M; Cáp J; Pecen L
Cytopathology; 2003 Feb; 14(1):27-31. PubMed ID: 12588307
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
15. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions.
Oestreicher-Kedem Y; Halpern M; Roizman P; Hardy B; Sulkes J; Feinmesser R; Stern Y
Head Neck; 2004 Nov; 26(11):960-6. PubMed ID: 15386597
[TBL] [Abstract][Full Text] [Related]
17. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
Stremenova J; Krepela E; Mares V; Trim J; Dbaly V; Marek J; Vanickova Z; Lisa V; Yea C; Sedo A
Int J Oncol; 2007 Oct; 31(4):785-92. PubMed ID: 17786309
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma.
Kesmodel SB; Terhune KP; Canter RJ; Mandel SJ; LiVolsi VA; Baloch ZW; Fraker DL
Surgery; 2003 Dec; 134(6):1005-12; discussion 1012. PubMed ID: 14668734
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic contribution of HBME-1 and anti-cytokeratin-19 antibodies in thyroid pathology: a retrospective study of 163 cases].
Ziadi S; Trimeche M; Zermani R; Elmay A; Baltagi-Ben Jilani S
Tunis Med; 2005 May; 83(5):274-8. PubMed ID: 16044900
[TBL] [Abstract][Full Text] [Related]
20. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
